AntibioticMech

Browse · ANTIBACTERIAL

nalidixic acid

CHEBI:100147 ·resolve ·ANTIBACTERIAL ·EXACT SEEDED

A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively. An orally administered antibacterial, it is used in the treatment of lower urinary-tract infections due to Gram-negative bacteria, including the majority of E. coli, Enterobacter, Klebsiella, and Proteus species. — ChEBI

Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.

Classification

fluoroquinolone antibioticARO:0000001

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC12H12N2O3
Charge0
Average mass232.239 Da
Monoisotopic mass232.08479 Da
SourceChEBI
InChIKeyMHWLWQUZZRMNGJ-UHFFFAOYSA-N

SMILES

CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21

InChI

InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)

Also called

Cross-references

Identifiers for this same structure in other resources. An accession that lands on two different structures in this corpus is withheld from both rather than shown here, since it names at most one of them.

Drug registries

Identifiers that name a drug rather than a structure. One of these can cover a parent compound, its salts and its stereoisomers, which this corpus keeps as separate records, so it is not an equivalence of structure.

Patents and articles

Documents about this compound. A patent covers a class and an article covers a topic; neither identifies a structure.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
ARO ARO:3000661 nalidixic acid antibioticmech:aro-4cf71250ed 2026-08-30
CHEBI CHEBI:100147 nalidixic acid antibioticmech:chebi-561a3b207f 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

fluoroquinolone sensitive gyrA PROTEIN DIRECT_BINDING_TARGET

ARO:3000733

CARD/ARO database assertion; target organism, strain, and assay are not specified. ARO explicitly describes ligand binding to gyrase subunit A. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

DNA topoisomerase 4 subunit A [V210L]/B PROTEIN_COMPLEX MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Bacillus subtilis NCBITaxon:1423

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 1090000 nM DNA Topoisomerase IV Assay
The 50% inhibitory concentration (IC50) is defined as the concentration of compound that inhibits the decatenation of kinetoplast DNA by 50%.
RSID 39230
assay 2532_2
monomer 21691
PMID:17074800
Organism-specific examples
ProteinGeneOrganismEntry
DNA topoisomerase 4 subunit A UniProtKB:Q45066
BindingDB target chain 1
— Bacillus subtilis NCBITaxon:1423 REVIEWED
DNA topoisomerase 4 subunit B UniProtKB:Q59192
BindingDB target chain 2
— Bacillus subtilis NCBITaxon:1423 REVIEWED

Mechanism summary

Mode of action
NUCLEIC_ACID_SYNTHESIS_INHIBITION microbial target — CURATOR: Confirmed as bacterial DNA gyrase poisoning after primary nalidixic acid mechanism review. PMID:200930.
Clinical status
APPROVED

Resistance mechanisms

35 source-backed resistance determinants or associations, with ARO grounding where reported. Grouped by reported mechanism type.

ANTIBIOTIC_TARGET_ALTERATION 27
ANTIBIOTIC_TARGET_ALTERATION
DeterminantARO IDOrganismGene familiesEvidence
Acinetobacter baumannii gyrA conferring resistance to fluoroquinolones ARO:3003817 not organism-specific —
  • ARO:3003817 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Acinetobacter baumannii parC conferring resistance to fluoroquinolones ARO:3003818 not organism-specific —
  • ARO:3003818 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Bartonella bacilliformis gyrA conferring resistance to fluoroquinolones ARO:3003297 not organism-specific —
  • ARO:3003297 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Escherichia coli gyrA conferring resistance to fluoroquinolones ARO:3003294 not organism-specific —
  • ARO:3003294 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Escherichia coli parC conferring resistance to fluoroquinolones ARO:3003308 not organism-specific —
  • ARO:3003308 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Escherichia coli parE conferring resistance to fluoroquinolones ARO:3003316 not organism-specific —
  • ARO:3003316 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Escherichia coli soxR with mutation conferring antibiotic resistance ARO:3003381 not organism-specific —
  • ARO:3003381 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Morganella morganii gyrB conferring resistance to fluoroquinolones ARO:3003306 not organism-specific —
  • ARO:3003306 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Mycobacterium leprae gyrA conferring resistance to fluoroquinolones ARO:3003298 not organism-specific —
  • ARO:3003298 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Mycobacterium leprae gyrB conferring resistance to fluoroquinolones ARO:3003304 not organism-specific —
  • ARO:3003304 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones ARO:3003295 not organism-specific —
  • ARO:3003295 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Mycobacterium tuberculosis gyrB with mutation conferring resistance to fluoroquinolones ARO:3003459 not organism-specific —
  • ARO:3003459 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Mycoplasma hominis parC conferring resistance to fluoroquinolones ARO:3003310 not organism-specific —
  • ARO:3003310 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Salmonella enterica gyrA conferring resistance to fluoroquinolones ARO:3003926 not organism-specific —
  • ARO:3003926 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Salmonella enterica parC conferring resistance to fluoroquinolones ARO:3003939 not organism-specific —
  • ARO:3003939 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Salmonella isangi gyrA conferring resistance to fluoroquinolones ARO:3007751 not organism-specific —
  • ARO:3007751 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Salmonella isangi gyrB conferring resistance to fluoroquinolones ARO:3007752 not organism-specific —
  • ARO:3007752 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Salmonella serovars gyrB conferring resistance to fluoroquinolones ARO:3003307 not organism-specific —
  • ARO:3003307 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Salmonella serovars parE conferring resistance to fluoroquinolones
Evidence-scope review 2026-10-16-salmonella-pare-evidence-scope: The cited Enteritidis study found no independent parE effect in its tested background; an indirect contribution remained unresolved. This is not a universal inactivity claim or evidence for every serovar and inherited compound. Retain CARD's assertion as database evidence, without assigning an experimental protein, allele, taxon or susceptibility observation. Qualification references, not an upgrade of the CARD assertion: DOI:10.1128/aac.01005-08 (Results: Contribution of target gene mutations to quinolone resistance; Table 1: quinolone headers and relevant parE comparison; Table 3: compound headers and absence of a parE-specific comparison; Discussion: paragraph beginning Although complementation; publisher HTML text and selected table text; no visual table, figure or supplement verification). Reviewed 2026-10-16 by Codex; curation/card_evidence_reviews.json SHA-256 584f3e32ce0122eb2315fe09bbe22e058539bef184ad2d75756a6f3016bf2687.
ARO:3003317 not organism-specific —
  • ARO:3003317 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Shigella flexneri gyrA conferring resistance to fluoroquinolones ARO:3003940 not organism-specific —
  • ARO:3003940 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Shigella flexneri parC conferring resistance to fluoroquinolones ARO:3003941 not organism-specific —
  • ARO:3003941 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Staphylococcus aureus gyrA conferring resistance to fluoroquinolones ARO:3003296 not organism-specific —
  • ARO:3003296 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Staphylococcus aureus parC conferring resistance to fluoroquinolones ARO:3003312 not organism-specific —
  • ARO:3003312 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Staphylococcus aureus parE conferring resistance to fluoroquinolones ARO:3003315 not organism-specific —
  • ARO:3003315 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Streptococcus pneumoniae parC conferring resistance to fluoroquinolones ARO:3003311 not organism-specific —
  • ARO:3003311 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Ureaplasma urealyticum gyrB conferring resistance to fluoroquinolones ARO:3003305 not organism-specific —
  • ARO:3003305 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Ureaplasma urealyticum parC conferring resistance to fluoroquinolones ARO:3003309 not organism-specific —
  • ARO:3003309 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
ANTIBIOTIC_EFFLUX 5
ANTIBIOTIC_EFFLUX
DeterminantARO IDOrganismGene familiesEvidence
Acinetobacter baumannii AbaQ ARO:3004574 not organism-specific —
  • ARO:3004574 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
EmrAB-TolC ARO:3000344 not organism-specific —
  • ARO:3000344 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
QepA4 ARO:3004379 not organism-specific —
  • ARO:3004379 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
mdeA ARO:3007011 not organism-specific —
  • ARO:3007011 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
putative nickel/cobalt transporter ARO:3007659 not organism-specific —
  • ARO:3007659 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
REDUCED_PERMEABILITY 2
REDUCED_PERMEABILITY
DeterminantARO IDOrganismGene familiesEvidence
Escherichia coli LamB ARO:3004126 not organism-specific —
  • ARO:3004126 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
Escherichia coli mipA ARO:3004127 not organism-specific —
  • ARO:3004127 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)
ANTIBIOTIC_TARGET_PROTECTION 1
ANTIBIOTIC_TARGET_PROTECTION
DeterminantARO IDOrganismGene familiesEvidence
quinolone resistance protein (qnr) ARO:3000419 not organism-specific —
  • ARO:3000419 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000661 (nalidixic acid); database assertion, not a primary citation.)

Causal graphs

Evidence-backed mechanism graphs: how the compound reaches its target, what the target does, and how the effect propagates to growth inhibition or death.

Nalidixic acid poisons bacterial DNA gyrase MECHANISTIC

Nalidixic acid acts on the GyrA-containing bacterial DNA gyrase complex, trapping a protein-linked DNA cleavage state that blocks completion of DNA topology-changing reactions.

Nodes — nalidixic_acid_gyrase_cleavage_complex
NodeLabelTypeGrounding
nalidixic_acid nalidixic acid COMPOUND CHEBI:100147
dna_gyrase bacterial DNA gyrase
Examples: DNA gyrase subunit A (gyrA) UniProtKB:P0AES4, Escherichia coli (strain K12) NCBITaxon:83333 REVIEWED — GyrA subunit (formerly nalA gene product) of E. coli DNA gyrase that forms the nalidixic acid-stabilized DNA cleavage complex and controls supercoiling sensitivity (PMID:303505; PMID:217495; K-12 reference proteome context).; DNA gyrase subunit B (gyrB) UniProtKB:P0AES6, Escherichia coli (strain K12) NCBITaxon:83333 REVIEWED — ATPase GyrB subunit partnering with GyrA in the E. coli DNA gyrase holoenzyme inhibited by nalidixic acid (PMID:303505; PMID:217495; K-12 reference proteome context).
GENE_OR_PROTEIN ARO:3000733
gyrase_dna_cleavage_complex DNA gyrase covalent DNA cleavage complex STATE REVIEWED_LABEL_ONLY
dna_religation DNA gyrase DNA religation MOLECULAR_FUNCTION REVIEWED_LABEL_ONLY
dna_topology_control bacterial DNA topology control BIOLOGICAL_PROCESS REVIEWED_LABEL_ONLY
Edges — nalidixic_acid_gyrase_cleavage_complex
SubjectPredicateObjectEvidence
nalidixic_acid stabilizes gyrase_dna_cleavage_complex
  • PMID:200930 (Sugino and colleagues showed nalidixic and oxolinic acids inhibit E. coli DNA gyrase and induce a relaxation-complex analogue.)
dna_gyrase participates in gyrase_dna_cleavage_complex
  • PMID:200930 (Purified NalA/GyrA restored nalidixic acid sensitivity to DNA gyrase activity in biochemical assays.)
gyrase_dna_cleavage_complex inhibits dna_religation
  • PMID:200930 (Nalidixic acid-induced gyrase complexes generated covalently protein-linked linear DNA after detergent treatment.)
dna_religation supports dna_topology_control
  • PMID:200930 (The nalidixic acid-sensitive NalA/GyrA protein participated in DNA gyrase supertwisting and ATP-independent DNA relaxation.)

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (ARO, CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  6. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  7. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  8. CURATED_CAUSAL_GRAPH 2026-09-04 · codex · LLM-assisted

    Added a PMID-supported causal graph for nalidixic acid poisoning of bacterial DNA gyrase and marked the coarse target scope as curator-reviewed.

  9. RESEEDED_FROM_SOURCES 2026-09-10 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  10. RESEEDED_FROM_SOURCES 2026-10-16 · seed_from_sources

    Re-seeded; changed: resistance_mechanisms (CARD). Upstream retrieval date 2026-08-30, unchanged.

  11. CURATED_UNIPROT_PROTEIN_EXAMPLES 2026-10-18 · antigravity · LLM-assisted

    Added curated E. coli K-12 DNA gyrase subunit A (P0AES4) and subunit B (P0AES6) UniProtKB protein examples on the nalidixic_acid_gyrase_cleavage_complex dna_gyrase causal graph node.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record (YAML).

Explore across X-Mech: MediaIngredientMech (nalidixic acid) · CultureMech · NaturalProductMech · PathwayMech · TraitMech